Back
ESC Professional Premium Access

The long-term clinical course of moderate tricuspid regurgitation

Session: Epidemiology, prognosis, course, and outcome of valvular heart disease
Topic: Epidemiology, Prognosis, Outcome
Speaker: Doctor D. Margonato (Milan, IT)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Davide Margonato

San Raffaele Hospital, Milan (Italy)
0 follower

5 more presentations in this session

Tricuspid regurgitation: frequency, management and outcome among patients with severe left-sided valvular heart disease in Europe. Insights from the ESC-EORP valvular heart disease II survey

Speaker: Doctor J. Dreyfus (Saint-Denis, FR)

Access
Abstract
Slides
Like
Thumbnail

Outcomes benefit in asymptomatic patients with moderate aortic valve stenosis followed up in heart valve clinics

Speaker: Doctor P. Paolisso (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

Diabetes mellitus and cardiovascular mortality across the spectrum of aortic stenosis

Speaker: Associate Professor A. Coisne (Lille, FR)

Access
Abstract
Slides
Like
Thumbnail

Heritability and environmental influences on the onset of aortic valve sclerosis: a twin population study

Speaker: Doctor P. Poggio (Milan, IT)

Access
Abstract
Slides
Like
Thumbnail

Modeling aortic stenosis progression: impact on follow-up, treatment and survival

Speaker: Doctor R. Teixeira (Vila Nova de Gaia, PT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Epidemiology, prognosis, course, and outcome of valvular heart disease

Speakers: Doctor D. Margonato, Doctor J. Dreyfus, Doctor P. Paolisso, Associate Professor A. Coisne, Doctor P. Poggio...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources